Physician profile
Saw Sein
NPI 1053754473
$6,662.71
in general payments reported to CMS, 2019-2025
46 companies · $1,236 in 2025
The $1,236 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,307 · 2020: $1,170 · 2022: $689 · 2023: $742 · 2024: $1,519 · 2025: $1,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,496.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $739.15 | 2019-2025 | |
| Glaxosmithkline, LLC. | $729.05 | 2022-2025 | Shingrix, Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $727.59 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Novo Nordisk INC | $623.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $523.44 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Pfizer INC. | $460.24 | 2019-2025 | |
| Amgen INC. | $362.13 | 2019-2024 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $300.53 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $296.73 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $254.20 | 2019-2024 | Dupixent |
| Exact Sciences Corporation | $154.68 | 2024-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $143.70 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $130.60 | 2020-2024 | |
| Echosens North America, INC. | $98.73 | 2023 | Fibroscan |
| Hologic Sales and Service, LLC | $96.10 | 2019-2024 | Aptima, Thinprep 2000 Processor |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saw Sein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.